Today

Agents

Chat

Arena

Discover

More

App

Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule - RKDA News | Rallies

Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule

RKDA•2026-08-10

Nasdaq notice for minimum bid price noncompliance

Arcadia Biosciences received a Nasdaq notice on Aug. 4, 2026 for failing the $1 minimum bid price rule.

Noncompliance was triggered by 30 straight sessions below $1, from June 22, 2026 to Aug. 3, 2026.
RKDA keeps trading on the Nasdaq Capital Market while it has until Feb. 1, 2027 to regain compliance.
Compliance requires a closing bid price of at least $1 for 10 consecutive business days, subject to Nasdaq discretion.
A reverse stock split is among options under review; failure to cure could lead to delisting risk.

Related News

Lincoln Financial declares quarterly dividend of $0.45 a share

LNC•2026-08-10

Strive Q2 FY26 GAAP net loss widens to $257.6 million; revenue rises to $2.94 million

ASST•2026-08-10

Teledyne to acquire Varex Imaging in $1.1 billion deal

Sources

S

Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule

Sec

2026-08-10

MP Materials <MP.N>: Deutsche Bank cuts target price to $58 from $61

MP•2026-08-10

Csquare Inc <CSQR.N>: BMO initiates coverage with outperform rating; price target $26

CSQR•2026-08-10